Literature DB >> 18241691

9. Anaphylaxis.

F Estelle R Simons1.   

Abstract

Anaphylaxis is an acute-onset, potentially fatal systemic allergic reaction. It is usually triggered by an agent such as an insect sting, food, or medication, through a mechanism involving IgE and the high-affinity IgE receptor on mast cells or basophils. Less commonly, it is triggered through other immunologic mechanisms, or through nonimmunologic mechanisms. It often occurs in community settings. Anaphylaxis episodes range in severity from those that are mild and resolve spontaneously to those that are fatal within minutes. The clinical diagnosis is based on a meticulous history and physical examination, sometimes, but not necessarily, supported by a laboratory test such as an elevated serum total tryptase level. Sensitization to allergen triggers suggested by the history needs to be confirmed by skin testing and measurement of allergen-specific IgE. In some sensitized individuals, additional tests are needed to assess the risk of future anaphylaxis episodes. Prompt injection of epinephrine is life-saving. H1-antihistamines and inhaled beta2-adrenergic agonists cannot be depended on to prevent fatality. Long-term risk reduction is an integral part of management.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18241691     DOI: 10.1016/j.jaci.2007.08.061

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  18 in total

Review 1.  State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve?

Authors:  Salvatore Chirumbolo
Journal:  Blood Transfus       Date:  2011-12-21       Impact factor: 3.443

2.  Diagnostic utility of two case definitions for anaphylaxis: a comparison using a retrospective case notes analysis in the UK.

Authors:  Michel Erlewyn-Lajeunesse; Sandra Dymond; Ingrid Slade; Helen L Mansfield; Rosie Fish; Owen Jones; Jonathan R Benger
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

Review 3.  [Value of in-vitro diagnostic tools after anaphylaxis].

Authors:  L Vanstreels; H F Merk
Journal:  Hautarzt       Date:  2013-02       Impact factor: 0.751

4.  Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice.

Authors:  Ana Olivera; Christoph Eisner; Yoshiaki Kitamura; Sandra Dillahunt; Laura Allende; Galina Tuymetova; Wendy Watford; Francoise Meylan; Susanne C Diesner; Lingli Li; Jurgen Schnermann; Richard L Proia; Juan Rivera
Journal:  J Clin Invest       Date:  2010-04-19       Impact factor: 14.808

5.  Socioeconomic factors and epinephrine prescription in children with peanut allergy.

Authors:  Robin Coombs; Elinor Simons; Richard G Foty; David M Stieb; Sharon D Dell
Journal:  Paediatr Child Health       Date:  2011-06       Impact factor: 2.253

6.  Anaphylactoid reaction after injection of ketorolac in a loading dose for patient-controlled analgesia -A case report-.

Authors:  Hyun Sik Chung; Eun Sung Kim; Young June You; Chul Soo Park
Journal:  Korean J Anesthesiol       Date:  2010-06-23

Review 7.  Mechanisms of mast cell signaling in anaphylaxis.

Authors:  Dean D Metcalfe; Richard D Peavy; Alasdair M Gilfillan
Journal:  J Allergy Clin Immunol       Date:  2009-10       Impact factor: 10.793

8.  Polyethylene Glycol (PEG)-Induced Anaphylactic Reaction During Bowel Preparation.

Authors:  David Gachoka
Journal:  ACG Case Rep J       Date:  2015-07-09

9.  Eight years of severe allergic reactions in Finland: a register-based report.

Authors:  Soili Mäkinen-Kiljunen; Tari Haahtela
Journal:  World Allergy Organ J       Date:  2008-11       Impact factor: 4.084

10.  Curcumin inhibits the activation of immunoglobulin e-mediated mast cells and passive systemic anaphylaxis in mice by reducing serum eicosanoid and histamine levels.

Authors:  Xian Li; Yue Lu; Ye Jin; Jong-Keun Son; Seung Ho Lee; Hyeun Wook Chang
Journal:  Biomol Ther (Seoul)       Date:  2014-01       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.